Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 77 entries
Sorted by: Best Match Show Resources per page
Second-Harmonic Coherent Driving of a Spin Qubit in a Si/SiGe Quantum Dot.

Physical review letters

Scarlino P, Kawakami E, Ward DR, Savage DE, Lagally MG, Friesen M, Coppersmith SN, Eriksson MA, Vandersypen LM.
PMID: 26382693
Phys Rev Lett. 2015 Sep 04;115(10):106802. doi: 10.1103/PhysRevLett.115.106802. Epub 2015 Sep 01.

We demonstrate coherent driving of a single electron spin using second-harmonic excitation in a Si/SiGe quantum dot. Our estimates suggest that the anharmonic dot confining potential combined with a gradient in the transverse magnetic field dominates the second-harmonic response....

Cite
Scarlino P, Kawakami E, Ward DR, et al. Second-Harmonic Coherent Driving of a Spin Qubit in a Si/SiGe Quantum Dot. Phys Rev Lett. 2015;115(10):106802doi: 10.1103/PhysRevLett.115.106802.
Scarlino, P., Kawakami, E., Ward, D. R., Savage, D. E., Lagally, M. G., Friesen, M., Coppersmith, S. N., Eriksson, M. A., & Vandersypen, L. M. (2015). Second-Harmonic Coherent Driving of a Spin Qubit in a Si/SiGe Quantum Dot. Physical review letters, 115(10), 106802. https://doi.org/10.1103/PhysRevLett.115.106802
Scarlino, P, et al. "Second-Harmonic Coherent Driving of a Spin Qubit in a Si/SiGe Quantum Dot." Physical review letters vol. 115,10 (2015): 106802. doi: https://doi.org/10.1103/PhysRevLett.115.106802
Scarlino P, Kawakami E, Ward DR, Savage DE, Lagally MG, Friesen M, Coppersmith SN, Eriksson MA, Vandersypen LM. Second-Harmonic Coherent Driving of a Spin Qubit in a Si/SiGe Quantum Dot. Phys Rev Lett. 2015 Sep 04;115(10):106802. doi: 10.1103/PhysRevLett.115.106802. Epub 2015 Sep 01. PMID: 26382693.
Copy Download .nbib Format: NLM
The obstructed kidney: a pediatric problem.

Journal of the Medical Association of Georgia

SCARDINO PL, PRINCE CL.
PMID: 14442234
J Med Assoc Ga. 1960 Jul;49:349-53.

No abstract available.

Cite
SCARDINO PL, PRINCE CL. The obstructed kidney: a pediatric problem. J Med Assoc Ga. 1960;49:349-53
SCARDINO, P. L., & PRINCE, C. L. (1960). The obstructed kidney: a pediatric problem. Journal of the Medical Association of Georgia, 49349-53.
SCARDINO, P L, and PRINCE, C L. "The obstructed kidney: a pediatric problem." Journal of the Medical Association of Georgia vol. 49 (1960): 349-53.
SCARDINO PL, PRINCE CL. The obstructed kidney: a pediatric problem. J Med Assoc Ga. 1960 Jul;49:349-53. PMID: 14442234.
Copy Download .nbib Format: NLM
The physician and conflict of interest.

Nature clinical practice. Urology

Scardino PT, Farley SJ.
PMID: 16474685
Nat Clin Pract Urol. 2005 Mar;2(3):113. doi: 10.1038/ncpuro0125.

No abstract available.

Cite
Scardino PT, Farley SJ. The physician and conflict of interest. Nat Clin Pract Urol. 2005;2(3):113doi: 10.1038/ncpuro0125.
Scardino, P. T., & Farley, S. J. (2005). The physician and conflict of interest. Nature clinical practice. Urology, 2(3), 113. https://doi.org/10.1038/ncpuro0125
Scardino, Peter T, and Farley, Suzanne J. "The physician and conflict of interest." Nature clinical practice. Urology vol. 2,3 (2005): 113. doi: https://doi.org/10.1038/ncpuro0125
Scardino PT, Farley SJ. The physician and conflict of interest. Nat Clin Pract Urol. 2005 Mar;2(3):113. doi: 10.1038/ncpuro0125. PMID: 16474685.
Copy Download .nbib Format: NLM
Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age: data from the malmö preventive project.

Oncotarget

Assel MJ, Gerdtsson A, Thorek DLJ, Carlsson SV, Malm J, Scardino PT, Vickers A, Lilja H, Ulmert D.
PMID: 29464033
Oncotarget. 2017 Dec 05;9(5):5778-5785. doi: 10.18632/oncotarget.22981. eCollection 2018 Jan 19.

OBJECTIVES: To evaluate whether anthropometric parameters add to PSA measurements in middle-aged men for risk assessment of prostate cancer (PCa) diagnosis and death.RESULTS: After adjusting for PSA, both BMI and weight were significantly associated with an increased risk of...

Cite
Assel MJ, Gerdtsson A, Thorek DLJ, et al. Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age: data from the malmö preventive project. Oncotarget. 2017;9(5):5778-5785doi: 10.18632/oncotarget.22981.
Assel, M. J., Gerdtsson, A., Thorek, D. L. J., Carlsson, S. V., Malm, J., Scardino, P. T., Vickers, A., Lilja, H., & Ulmert, D. (2018). Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age: data from the malmö preventive project. Oncotarget, 9(5), 5778-5785. https://doi.org/10.18632/oncotarget.22981
Assel, Melissa J, et al. "Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age: data from the malmö preventive project." Oncotarget vol. 9,5 (2018): 5778-5785. doi: https://doi.org/10.18632/oncotarget.22981
Assel MJ, Gerdtsson A, Thorek DLJ, Carlsson SV, Malm J, Scardino PT, Vickers A, Lilja H, Ulmert D. Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age: data from the malmö preventive project. Oncotarget. 2017 Dec 05;9(5):5778-5785. doi: 10.18632/oncotarget.22981. eCollection 2018 Jan 19. PMID: 29464033; PMCID: PMC5814173.
Copy Download .nbib Format: NLM
Use of the Electronic Health Record to Optimize Antimicrobial Prescribing.

Clinical therapeutics

Parzen-Johnson S, Kronforst KD, Shah RM, Whitmer GR, Scardina T, Chandarraju M, Patel SJ.
PMID: 34645574
Clin Ther. 2021 Oct;43(10):1681-1688. doi: 10.1016/j.clinthera.2021.09.009. Epub 2021 Oct 10.

PURPOSE: This review summarizes how interventions in the electronic health record (EHR) can optimize antimicrobial stewardship across the continuum of antimicrobial decision making, from diagnosis of infection to discontinuation of therapy. In addition, opportunities to optimize provider communication and...

Cite
Parzen-Johnson S, Kronforst KD, Shah RM, et al. Use of the Electronic Health Record to Optimize Antimicrobial Prescribing. Clin Ther. 2021;43(10):1681-1688doi: 10.1016/j.clinthera.2021.09.009.
Parzen-Johnson, S., Kronforst, K. D., Shah, R. M., Whitmer, G. R., Scardina, T., Chandarraju, M., & Patel, S. J. (2021). Use of the Electronic Health Record to Optimize Antimicrobial Prescribing. Clinical therapeutics, 43(10), 1681-1688. https://doi.org/10.1016/j.clinthera.2021.09.009
Parzen-Johnson, Simon, et al. "Use of the Electronic Health Record to Optimize Antimicrobial Prescribing." Clinical therapeutics vol. 43,10 (2021): 1681-1688. doi: https://doi.org/10.1016/j.clinthera.2021.09.009
Parzen-Johnson S, Kronforst KD, Shah RM, Whitmer GR, Scardina T, Chandarraju M, Patel SJ. Use of the Electronic Health Record to Optimize Antimicrobial Prescribing. Clin Ther. 2021 Oct;43(10):1681-1688. doi: 10.1016/j.clinthera.2021.09.009. Epub 2021 Oct 10. PMID: 34645574.
Copy Download .nbib Format: NLM
A rapid assessment of litter magnitudes and impacts along the Torre Guaceto marine protected area (Brindisi, Italy).

Marine pollution bulletin

Rizzo A, Rangel-Buitrago N, Impedovo A, Mastronuzzi G, Scardino G, Scicchitano G.
PMID: 34601251
Mar Pollut Bull. 2021 Dec;173:112987. doi: 10.1016/j.marpolbul.2021.112987. Epub 2021 Oct 01.

This study focuses on assessing litter magnitudes along the Torre Guaceto Marine Protected Area (Brindisi, Italy). Collected litter was grouped into twenty different types and classified into four litter typologies according to the Guidance on Monitoring of Marine Litter...

Cite
Rizzo A, Rangel-Buitrago N, Impedovo A, et al. A rapid assessment of litter magnitudes and impacts along the Torre Guaceto marine protected area (Brindisi, Italy). Mar Pollut Bull. 2021;173:112987doi: 10.1016/j.marpolbul.2021.112987.
Rizzo, A., Rangel-Buitrago, N., Impedovo, A., Mastronuzzi, G., Scardino, G., & Scicchitano, G. (2021). A rapid assessment of litter magnitudes and impacts along the Torre Guaceto marine protected area (Brindisi, Italy). Marine pollution bulletin, 173112987. https://doi.org/10.1016/j.marpolbul.2021.112987
Rizzo, Angela, et al. "A rapid assessment of litter magnitudes and impacts along the Torre Guaceto marine protected area (Brindisi, Italy)." Marine pollution bulletin vol. 173 (2021): 112987. doi: https://doi.org/10.1016/j.marpolbul.2021.112987
Rizzo A, Rangel-Buitrago N, Impedovo A, Mastronuzzi G, Scardino G, Scicchitano G. A rapid assessment of litter magnitudes and impacts along the Torre Guaceto marine protected area (Brindisi, Italy). Mar Pollut Bull. 2021 Dec;173:112987. doi: 10.1016/j.marpolbul.2021.112987. Epub 2021 Oct 01. PMID: 34601251.
Copy Download .nbib Format: NLM
A Case of Cyclic Neutropenia and Associated Amyloidosis.

Journal of pediatric hematology/oncology

Ilonze C, Galipp KM, Scordino T, Meyer WH, Baker A.
PMID: 34224518
J Pediatr Hematol Oncol. 2021 Nov 01;43(8):e1115-e1117. doi: 10.1097/MPH.0000000000002217.

Cyclic neutropenia has been rarely associated with chronic inflammation and development of reactive AA amyloidosis. We report a family with cyclic neutropenia with associated renal and thyroid amyloid. A 12-year-old female presented with thyromegaly, recurrent aphthous ulcers, severe neutropenia,...

Cite
Ilonze C, Galipp KM, Scordino T, et al. A Case of Cyclic Neutropenia and Associated Amyloidosis. J Pediatr Hematol Oncol. 2021;43(8):e1115-e1117doi: 10.1097/MPH.0000000000002217.
Ilonze, C., Galipp, K. M., Scordino, T., Meyer, W. H., & Baker, A. (2021). A Case of Cyclic Neutropenia and Associated Amyloidosis. Journal of pediatric hematology/oncology, 43(8), e1115-e1117. https://doi.org/10.1097/MPH.0000000000002217
Ilonze, Chibuzo, et al. "A Case of Cyclic Neutropenia and Associated Amyloidosis." Journal of pediatric hematology/oncology vol. 43,8 (2021): e1115-e1117. doi: https://doi.org/10.1097/MPH.0000000000002217
Ilonze C, Galipp KM, Scordino T, Meyer WH, Baker A. A Case of Cyclic Neutropenia and Associated Amyloidosis. J Pediatr Hematol Oncol. 2021 Nov 01;43(8):e1115-e1117. doi: 10.1097/MPH.0000000000002217. PMID: 34224518.
Copy Download .nbib Format: NLM
Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial.

European urology oncology

Touijer KA, Sjoberg DD, Benfante N, Laudone VP, Ehdaie B, Eastham JA, Scardino PT, Vickers A.
PMID: 33865797
Eur Urol Oncol. 2021 Aug;4(4):532-539. doi: 10.1016/j.euo.2021.03.006. Epub 2021 Apr 15.

BACKGROUND: Pelvic lymph node dissection (PLND) is the most reliable procedure for lymph node staging. However, the therapeutic benefit remains unproven; although most radical prostatectomies at academic centers are accompanied by PLND, there is no consensus regarding the optimal...

Cite
Touijer KA, Sjoberg DD, Benfante N, et al. Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial. Eur Urol Oncol. 2021;4(4):532-539doi: 10.1016/j.euo.2021.03.006.
Touijer, K. A., Sjoberg, D. D., Benfante, N., Laudone, V. P., Ehdaie, B., Eastham, J. A., Scardino, P. T., & Vickers, A. (2021). Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial. European urology oncology, 4(4), 532-539. https://doi.org/10.1016/j.euo.2021.03.006
Touijer, Karim A, et al. "Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial." European urology oncology vol. 4,4 (2021): 532-539. doi: https://doi.org/10.1016/j.euo.2021.03.006
Touijer KA, Sjoberg DD, Benfante N, Laudone VP, Ehdaie B, Eastham JA, Scardino PT, Vickers A. Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial. Eur Urol Oncol. 2021 Aug;4(4):532-539. doi: 10.1016/j.euo.2021.03.006. Epub 2021 Apr 15. PMID: 33865797; PMCID: PMC8407534.
Copy Download .nbib Format: NLM
Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsy.

Cancer reports (Hoboken, N.J.)

Cuzick JM, Stone S, Lenz L, Flake DD, Rajamani S, Moller H, Berney DM, Cohen T, Scardino PT.
PMID: 34423592
Cancer Rep (Hoboken). 2021 Aug 22;e1535. doi: 10.1002/cnr2.1535. Epub 2021 Aug 22.

BACKGROUND: Validation of biomarker-based prognostic models to improve risk stratification in men with localized prostate cancer (PrCa) remains a clinical need. It has previously been shown that the cell cycle progression (CCP) test provides significant, independent prognostic information for...

Cite
Cuzick JM, Stone S, Lenz L, et al. Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsy. Cancer Rep (Hoboken). 2021;e1535doi: 10.1002/cnr2.1535.
Cuzick, J. M., Stone, S., Lenz, L., Flake, D. D., Rajamani, S., Moller, H., Berney, D. M., Cohen, T., & Scardino, P. T. (2021). Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsy. Cancer reports (Hoboken, N.J.), e1535. https://doi.org/10.1002/cnr2.1535
Cuzick, Jack M, et al. "Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsy." Cancer reports (Hoboken, N.J.) vol. (2021): e1535. doi: https://doi.org/10.1002/cnr2.1535
Cuzick JM, Stone S, Lenz L, Flake DD, Rajamani S, Moller H, Berney DM, Cohen T, Scardino PT. Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsy. Cancer Rep (Hoboken). 2021 Aug 22;e1535. doi: 10.1002/cnr2.1535. Epub 2021 Aug 22. PMID: 34423592.
Copy Download .nbib Format: NLM
Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.

Nature genetics

Carver BS, Tran J, Gopalan A, Chen Z, Shaikh S, Carracedo A, Alimonti A, Nardella C, Varmeh S, Scardino PT, Cordon-Cardo C, Gerald W, Pandolfi PP.
PMID: 32820258
Nat Genet. 2020 Sep;52(9):984. doi: 10.1038/s41588-020-0688-0.

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Cite
Carver BS, Tran J, Gopalan A, et al. Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet. 2020;52(9):984doi: 10.1038/s41588-020-0688-0.
Carver, B. S., Tran, J., Gopalan, A., Chen, Z., Shaikh, S., Carracedo, A., Alimonti, A., Nardella, C., Varmeh, S., Scardino, P. T., Cordon-Cardo, C., Gerald, W., & Pandolfi, P. P. (2020). Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nature genetics, 52(9), 984. https://doi.org/10.1038/s41588-020-0688-0
Carver, Brett S, et al. "Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate." Nature genetics vol. 52,9 (2020): 984. doi: https://doi.org/10.1038/s41588-020-0688-0
Carver BS, Tran J, Gopalan A, Chen Z, Shaikh S, Carracedo A, Alimonti A, Nardella C, Varmeh S, Scardino PT, Cordon-Cardo C, Gerald W, Pandolfi PP. Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet. 2020 Sep;52(9):984. doi: 10.1038/s41588-020-0688-0. PMID: 32820258.
Copy Download .nbib Format: NLM
Tapentadol vs oxycodone/naloxone in the management of pain after total hip arthroplasty in the fast track setting: an observational study.

Journal of experimental orthopaedics

D'Amato T, Martorelli F, Fenocchio G, Simili V, Kon E, Di Matteo B, Scardino M.
PMID: 31359202
J Exp Orthop. 2019 Jul 29;6(1):36. doi: 10.1186/s40634-019-0204-6.

BACKGROUND: In recent years, joint replacement surgery has gradually progressed towards the fast-track model, and early rehabilitation immediately after surgery is regarded fundamental for optimal recovery of function: the aim of the present study is to describe the efficacy...

Cite
D'Amato T, Martorelli F, Fenocchio G, et al. Tapentadol vs oxycodone/naloxone in the management of pain after total hip arthroplasty in the fast track setting: an observational study. J Exp Orthop. 2019;6(1):36doi: 10.1186/s40634-019-0204-6.
D'Amato, T., Martorelli, F., Fenocchio, G., Simili, V., Kon, E., Di Matteo, B., & Scardino, M. (2019). Tapentadol vs oxycodone/naloxone in the management of pain after total hip arthroplasty in the fast track setting: an observational study. Journal of experimental orthopaedics, 6(1), 36. https://doi.org/10.1186/s40634-019-0204-6
D'Amato, Tiziana, et al. "Tapentadol vs oxycodone/naloxone in the management of pain after total hip arthroplasty in the fast track setting: an observational study." Journal of experimental orthopaedics vol. 6,1 (2019): 36. doi: https://doi.org/10.1186/s40634-019-0204-6
D'Amato T, Martorelli F, Fenocchio G, Simili V, Kon E, Di Matteo B, Scardino M. Tapentadol vs oxycodone/naloxone in the management of pain after total hip arthroplasty in the fast track setting: an observational study. J Exp Orthop. 2019 Jul 29;6(1):36. doi: 10.1186/s40634-019-0204-6. PMID: 31359202; PMCID: PMC6663946.
Copy Download .nbib Format: NLM
Routine Postoperative Hemoglobin Assessment Poorly PredictsTransfusion Requirement among Patients Undergoing Minimally Invasive Radical Prostatectomy.

Urology practice

Chesnut GT, Benfante N, Barham D, Dean LW, Tin A, Sjoberg DD, Scardino PT, Eastham JA, Ehdaie B, Coleman JA, Donahue TF, Touijer KA, Laudone VP.
PMID: 32551332
Urol Pract. 2020 Jul;7(4):299-304. doi: 10.1097/UPJ.0000000000000108.

INTRODUCTION: An advantage of minimally invasive radical prostatectomy over open surgery is decreased blood loss. At our institution hemoglobin is routinely checked 4 and 14 hours postoperatively. We assessed the relevance of this practice in a contemporary cohort undergoing...

Cite
Chesnut GT, Benfante N, Barham D, et al. Routine Postoperative Hemoglobin Assessment Poorly PredictsTransfusion Requirement among Patients Undergoing Minimally Invasive Radical Prostatectomy. Urol Pract. 2020;7(4):299-304doi: 10.1097/UPJ.0000000000000108.
Chesnut, G. T., Benfante, N., Barham, D., Dean, L. W., Tin, A., Sjoberg, D. D., Scardino, P. T., Eastham, J. A., Ehdaie, B., Coleman, J. A., Donahue, T. F., Touijer, K. A., & Laudone, V. P. (2020). Routine Postoperative Hemoglobin Assessment Poorly PredictsTransfusion Requirement among Patients Undergoing Minimally Invasive Radical Prostatectomy. Urology practice, 7(4), 299-304. https://doi.org/10.1097/UPJ.0000000000000108
Chesnut, Gregory T, et al. "Routine Postoperative Hemoglobin Assessment Poorly PredictsTransfusion Requirement among Patients Undergoing Minimally Invasive Radical Prostatectomy." Urology practice vol. 7,4 (2020): 299-304. doi: https://doi.org/10.1097/UPJ.0000000000000108
Chesnut GT, Benfante N, Barham D, Dean LW, Tin A, Sjoberg DD, Scardino PT, Eastham JA, Ehdaie B, Coleman JA, Donahue TF, Touijer KA, Laudone VP. Routine Postoperative Hemoglobin Assessment Poorly PredictsTransfusion Requirement among Patients Undergoing Minimally Invasive Radical Prostatectomy. Urol Pract. 2020 Jul;7(4):299-304. doi: 10.1097/UPJ.0000000000000108. PMID: 32551332; PMCID: PMC7301724.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 77 entries